SMIM30 and acute myeloid leukemia: Consistent with a previous report identifying mTORC2 as a target of ZFP36 [24], our RIP data showed that mTORC2 3ʹ UTR was abundantly enriched by ZFP36 antibody, which was significantly increased after LINC00998 overexpression, suggesting that LINC00998 may be a key auxiliary for ZFP36 in AML cells.